Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Fractal Growth LLC currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is overseen by 1 distinct examiner, SAEED, ALI S, in 1 distinct art unit. SAEED, ALI S is the busiest examiner for the portfolio, managing the 1 busiest examiner pending action. This reflects a highly concentrated current workload for the company.
The involvement of 1 distinct examiner and 1 distinct art unit suggests a streamlined and focused prosecution process. Because there is only 1 pending office action, the applicant can concentrate on the specific feedback provided by SAEED, ALI S. This 1 busiest examiner pending status avoids the complexities of managing multiple examiners with different perspectives on biotechnology. The 1 distinct art unit involved will define the specific prior art landscape that the applicant must navigate for the 1 pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAEED, ALI S | 1 | 31.6% | +33.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17750102 | USE OF SOLUTIONS OF CANNABINOIDS FOR IMPROVING CANNABINOID PRODUCTION IN CANNABIS PLANTS TREATED THEREWITH | SAEED, ALI S | — |
| Art Unit | Apps |
|---|---|
| 1600 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17750102 | USE OF SOLUTIONS OF CANNABINOIDS FOR IMPROVING CANNABINOID PRODUCTION IN CANNABIS PLANTS TREATED THEREWITH | SAEED, ALI S | 1600 | §103 | Non-Final OA | — | Pending | May 20, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFractal Growth LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Ali S Saeed has the most, with 1 of Fractal Growth LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
